(Q40693490)

22 September 2017

The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids (English)

1 reference

22 September 2017

1 reference

1

E H Forrest

1 reference

22 September 2017

A J Morris

2

1 reference

22 September 2017

S Stewart

3

1 reference

22 September 2017

M Phillips

4

1 reference

22 September 2017

Y H Oo

5

1 reference

22 September 2017

N C Fisher

6

1 reference

22 September 2017

G Haydon

7

1 reference

22 September 2017

J O'Grady

8

1 reference

22 September 2017

C P Day

9

1 reference

22 September 2017

language of work or name

English

0 references

publication date

12 July 2007

1 reference

22 September 2017

1 reference

22 September 2017

56

1 reference

22 September 2017

12

1 reference

22 September 2017

1743-1746

1 reference

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

MELD accurately predicts mortality in patients with alcoholic hepatitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology

22 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

22 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

The treatment of alcoholic hepatitis

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095721

Alcoholic hepatitis--glucocorticosteroids or not?

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17627961

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.2006.099226

1 reference

22 September 2017

1 reference

22 September 2017

PubMed publication ID

17627961

1 reference